A Phase 1/2 Trial of ADI-270 in ccRCC

Clinical trial NCT06480565 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06480565
Sponsor: Adicet Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma

Start date: 2024-12-12
Primary completion: 2026-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.